Quarter Financials
Immix Biopharma, Inc. (IMMX)
$1.86
+0.03 (+1.64%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2020 Q4
|
|---|
| Net Income | -8 | -2 | -2 | -1 | -23 | -0 | -0 | - |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -38 | -34 | -33 | -31 | -30 | -7 | -7 | -5 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2020 Q4
|
|---|
| Capital Expenditure | - | - | - | - | - | - | - | - |
|---|
| Net PPE | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2020 Q4
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|